Patients with asthma with certain genotype combinations demonstrate more intense symptoms when combined with a close proximity to roadways, suggesting that traffic-related air pollution exposure may affect the likelihood of asthma diagnosis and exacerbations.
Patients with asthma with certain genotype combinations demonstrate more intense symptoms when combined with a close proximity to roadways, suggesting that traffic-related air pollution exposure may affect the likelihood of asthma diagnosis and exacerbations, according to a recent study published by Scientific Reports.
The researchers examined the associations between single nucleotide polymorphisms (SNPs) and the combinations of SNPs in the toll-like receptor 4 (TLR) pathway, residential distance to roadway as a proxy for traffic-related air pollution exposure, and asthma diagnosis and exacerbations.
The study considered individual data on genotype, residential address, asthma diagnosis, and exacerbations from the Environmental Polymorphisms Registry. Patients were divided into 3 groups—hyper-responders, hypo-responders, and neither—and they measured the participants' distance between their residence and nearest major road.
Patients with certain genetic profiles had exhibited more intense symptoms following exposure to traffic pollution. Furthermore, patients with asthma who lacked this genetic profile did not have the same sensitivity to traffic pollution and do not experience worse asthma symptoms.
The authors emphasized that the results are based on genetic variation and in order to further understand this concept, people should think of human genes as written instructions for making proteins, according to a press release.
"All humans have the same genes, in other words the same basic instructions, but in some people one DNA base pair has been changed," co-lead author Shepherd Schurman, MD, associate medical director of the National Institute of Environmental Health Sciences (NIEHS) Clinical Research Unit, said in a statement. "This common type of genetic variation is called a single nucleotide polymorphism or SNP, and it can alter the way proteins are made and make individuals more or less prone to illness."
Patients who were hyper-responders and lived close to heavily travelled roads were found to have the worst asthma symptoms, such as difficulty breathing, chest pain, cough, and wheezing. Patients with asthma who were hypo-responders and lived further from busy roads had milder symptoms.
"This research is a great example of how we can approach disease prevention on a personal level, and tailor our treatments to suit individual patients," she said. "That way we can be more efficient with our treatments and preventative measures, while at the same time cutting health care costs,” Janet Hall, MD, clinical director of NIEHS, said.
The researchers suggested that hyper-responders who are exposed to traffic pollution should receive air purification intervention, such as HEPA (high-efficiency particulate air) filters in their homes. Therefore, this study could enhance the quality of life for people with asthma in the future, according to the authors.
Reference
Schurman SH, Bravo MA, Innes CL. Toll-like receptor 4 pathway polymorphisms interact with pollution to influence asthma diagnosis and severity. Sci Rep. 2018;8(1):12713. doi: 10.1038/s41598-018-30865-0.
Exploring the Potential of Machine Learning in Optimizing Respiratory Failure Treatment
August 9th 2025Machine learning holds promise for optimizing treatment strategies and potentially improving outcomes in respiratory failure but future research and development are necessary to fully realize its potential in clinical practice.
Read More
Preventing Respiratory Illness and Death Through Tighter Air Quality Standards
June 1st 2021On this episode of Managed Care Cast, a research scholar at the Marron Institute of Urban Management at New York University discusses the latest findings in the Health of the Air report, which was presented at the recent American Thoracic Society 2021 International Conference.
Listen
RSV's Impact on Heart Health Emphasizes Broader Risks, Vaccination Importance for Older Adults
July 23rd 2025Respiratory syncytial virus (RSV) poses a significant, often overlooked, risk for serious cardiovascular complications in older adults, underscoring the need for vaccination in this population regardless of their preexisting health conditions.
Read More
Depemokimab Reduces Exacerbations Regardless of Baseline Asthma Control
July 3rd 2025Depemokimab significantly reduces asthma exacerbations, benefiting patients regardless of their baseline asthma control levels. A biologics license application for depemokimab is currently being reviewed by the FDA.
Read More